Skip to main content
Smart Investors Daily
MP

NYSE · MPLN

MultiPlan Corporation

Healthcare · Medical - Healthcare Information Services

$23.15

Down-$0.36 (-1.53%)

Updated Aug 28, 2026, 4:16 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
374.98M
P/E ratio
-1.87
Dividend yield
0.00%
52-week range
— – —
Volume
204.84K
Avg. volume
210.02K

Price performance

MPLN price history

1M range · 0 trading sessions · Daily adjusted prices

MPLN does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MPLN news

The latest Smart Investors Daily articles mentioning MPLN.

MPLN research

Overview

Company profile and research snapshot.

Company profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$10.00
Implied upside
Analysts
MPLN recent ratings
DateFirmRatingTarget
Jan 10, 2025CitigroupNeutral
Sep 23, 2024CitigroupNeutral
Aug 7, 2024Piper SandlerNeutral
Jun 26, 2024Piper SandlerNeutral
Mar 8, 2023CitigroupNeutral
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Oct 24, 2024

AMA, ISMS Antitrust Lawsuit Seeks to Break the MultiPlan Price Fixing Cartel

The AMA and ISMS have filed a lawsuit against MultiPlan, alleging that the data analytics agency is at the center of a price-fixing conspiracy with commercial health insurance companies. This has resulted in lower payments for out-of-network healthcare services, harming both patients and physicians.

Benzinga · Jan 26, 2024

Top 4 Health Care Stocks That May Explode This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. Mesoblast Limited (NASDAQ: MESO) On Jan. 19, the FDA granted Rare Pediatric Disease Designation to Mesoblast's Revascor® for treating children with congenital heart disease. The ...

Benzinga · Jan 18, 2023

Analyst Expectations for MultiPlan's Future

MultiPlan (NYSE:MPLN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 1 0 0 3M Ago 1 0 1 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, MultiPlan has an average price target of $2.01 with a high of $3.00 and a low of $1.00. Below is a summary of how these 4 analysts rated MultiPlan over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the ...Full story available on Benzinga.com

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.